Green Lifescience Co., Ltd. (KOSDAQ:114450)

South Korea · Delayed Price · Currency is KRW

2,215.00

+10.00 (0.45%)

At close: Sep 18, 2026

Market Cap	43.25B -18.9%
Revenue (ttm)	58.57B +111.0%
Net Income	7.36B
EPS	375.56
Shares Out	19.53M
PE Ratio	5.90
Forward PE	n/a
Dividend	112.50 (5.08%)
Ex-Dividend Date	n/a

Volume	39,995
Open	2,205.00
Previous Close	2,205.00
Day's Range	2,205.00 - 2,255.00
52-Week Range	1,673.00 - 4,590.00
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 2005

Employees 70

Stock Exchange KOSDAQ

Ticker Symbol 114450

Full Company Profile

Financial Performance

In 2025, Green Lifescience's revenue was 40.34 billion, an increase of 62.26% compared to the previous year's 24.86 billion. Earnings were 110.13 million, a decrease of -92.95%.

Financial Statements